Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 3.9B | 4.0B | 6.3B | 3.8B |
Cost of revenue | 3.1B | 2.4B | 2.8B | 2.2B |
Gross profit | 793M | 1.6B | 3.5B | 1.6B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 391M | 464M | 411M | 375M |
Other operating expenses | — | — | — | — |
Operating income | -120M | 599M | 2.6B | 808M |
Non operating interest income | ||||
Income | 6M | 15M | 9M | 18M |
Expense | 243M | 209M | 224M | 230M |
Other income expense | -59M | 73M | 43M | 52M |
Pretax income | -444M | 451M | 2.4B | 626M |
Tax provision | -176M | -39M | 555M | 159M |
Net income | -268M | 490M | 1.8B | 467M |
Basic EPS | -0.9 | — | 5.5 | 1.1 |
Diluted EPS | -0.9 | — | 5.5 | 1.1 |
Basic average shares | 339.8M | — | 340.7M | 345.3M |
Diluted average shares | 339.8M | — | 340.7M | 345.3M |
EBITDA | 619M | 1.3B | 3.4B | 1.5B |
Net income from continuing op. | -268M | 490M | 1.8B | 467M |
Minority interests | 0 | -49M | 51M | -102M |
Preferred stock dividends | — | — | — | — |